Copyright
©The Author(s) 2015.
World J Diabetes. Jul 10, 2015; 6(7): 983-989
Published online Jul 10, 2015. doi: 10.4239/wjd.v6.i7.983
Published online Jul 10, 2015. doi: 10.4239/wjd.v6.i7.983
Table 1 Characteristics of South Asian volunteers
Characteristics of 29 South Asian volunteers | Mean (SD) |
Age (yr) | 34.6 (8.9) |
Weight (kg) | 69.6 (18.4) |
Body-mass index (kg/m2) | 25 (5.2) |
Waist circumference (cm) | 86.8 (16.3) |
Hip circumference (cm) | 101 (10) |
Hip to waist ratio | 0.892 (0.144) |
Systolic BP (mmHg) | 119 (13) |
Diastolic BP (mmHg) | 75.8 (8.8) |
Energy from carbohydrates (%) | 45 (6.3) |
Energy from fats (%) | 40.8 (5.8) |
Energy from protein (%) | 9.4 (6.8) |
Energy from sugars (%) | 12.6 (7.5) |
Energy from starch (%) | 32 (8.5) |
Energy from saturated fat (%) | 9.7 (5.8) |
Energy from monounsaturated fat (%) | 10.7 (5.2) |
Energy from polyunsaturated fat (%) | 6.8 (2.9) |
Energy from alcohol (%) | 0.5 (2.2) |
Table 2 Fasting metabolic indices and monocyte CD36 expression amongst South Asian volunteers
Characteristics of 29 South Asian volunteers | Median (interquartile range) |
Plasma glucose (mmol/L) | 5.09 (4.50, 5.47) |
Serum NEFA (mmol/L) | 0.416 (0.264, 0.514) |
Serum cholesterol (mmol/L) | 3.41 (2.95, 3.96) |
Serum triglycerides (mmol/L) | 0.9 (0.67, 1.44) |
HDL cholesterol (mmol/L) | 1.27 (0.98, 1.48) |
LDL cholesterol (mmol/L) | 2.03 (1.56, 2.44) |
Apolipoprotein AI (g/L) | 1.21 (1.10, 1.43) |
Apolipoprotein B (g/L) | 0.58 (0.46, 0.77) |
VLDL subfraction cholesterol (mmol/L) | 1.26 (0.97, 1.44) |
LDL subfraction cholesterol (mmol/L) | 1.3 (0.80, 1.65) |
HDL2 subfraction cholesterol (mmol/L) | 0.58 (0.41, 0.76) |
HDL3 subfraction cholesterol (mmol/L) | 0.37 (0.25, 0.51) |
VLDL subfraction triglyceride (mmol/L) | 0.34 (0.24, 0.43) |
LDL subfraction triglyceride (mmol/L) | 0.27 (0.17, 0.55) |
HDL2 subfraction triglyceride (mmol/L) | 0.08 (0.06, 0.15) |
HDL3 subfraction triglyceride (mmol/L) | 0.06 (0.04, 0.08) |
Insulin (mU/L) | 4.64 (2.60, 8.23) |
Adiponectin (ng/mL) | 1.79 (0.65, 2.65) |
Plasma soluble CD36 (mmol/L) | 108 (0, 249) |
Total monocyte CD36 (Mon CD36+ per μL) | 361 (301, 432) |
Monocyte CD36 on Mon1 (%) | 81.8 (75.1, 85.8) |
Monocyte CD36 on Mon2 (%) | 7.2 (5.0, 10.3) |
Monocyte CD36 on Mon3 (%) | 10.5 (8.7, 16.6) |
Table 3 Correlation between characteristics and fasting metabolic indices against percentage monocyte CD36 expression
Characteristics and fasting metabolic indices | Spearman correlation coefficient (P) | ||
Mon1 | Mon2 | Mon3 | |
Body-mass index | -0.438 (0.02) | 0.156 (0.43) | 0.418 (0.027) |
Hip circumference | -0.633 (0.002) | 0.419 (0.06) | 0.483 (0.027) |
Serum NEFA | -0.349 (0.06) | 0.151 (0.43) | 0.478 (0.009) |
Apolipoprotein AI | -0.282 (0.14) | 0.475 (0.009) | 0.149 (0.44) |
Energy from total fat (%) | -0.472 (0.036) | 0.399 (0.08) | 0.458 (0.04) |
Energy from monounsaturated fat (%) | -0.691 (< 0.001) | 0.724 (< 0.001) | 0.230 (0.33) |
Energy from carbohydrates (%) | 0.645 (0.002) | -0.496 (0.026) | -0.533 (0.016) |
Table 4 Changes in metabolic factors absolute monocyte CD36 expression pre and post administration of oral glucose
Circulating concentrations following the administration of glucose | P | |||
0 min | 30 min | 120 min | ||
Monocyte CD36 on Mon1 (Mon CD36+ per μL) | 300 (240, 324) | 223 (187, 254) | 353 (323, 382) | < 0.001 |
Monocyte CD36 on Mon2 (Mon CD36+ per μL) | 23.9 (17.9, 32.3) | 21.3 (17.2, 30.8) | 29.9 (18.1, 39.6) | 0.011 |
Monocyte CD36 on Mon3 (Mon CD36+ per μL) | 36.7 (24.3, 53.2) | 26.1 (18.4, 45.8) | 34.4 (31.3, 48.7) | 0.03 |
Total monocyte CD36 (Mon CD36+ per μL) | 361 (308, 432) | 278 (240, 324) | 422 (394, 458) | < 0.001 |
Plasma glucose (mmol/L) | 5.09 (4.5, 5.47) | 6.68 (4.93, 8.12) | 5.2 (4.64, 6.07) | 0.08 |
Serum NEFA (mmol/L) | 0.416 (0.264, 0.514) | 0.215 (0.098, 0.326) | 0.094 (0.071, 0.207) | < 0.001 |
Serum cholesterol (mmol/L) | 3.41 (2.95, 3.96) | 3.29 (2.95, 3.95) | 3.44 (3.06, 3.80) | 0.52 |
Serum triglycerides (mmol/L) | 0.9 (0.67, 1.44) | 0.83 (0.55, 1.19) | 1.01 (0.54, 1.35) | 0.26 |
VLDL cholesterol (mmol/L)1 | 1.26 (0.97, 1.44) | 1.31 (0.94, 1.50) | 1.42 (1.27, 1.62) | 0.001 |
LDL cholesterol (mmol/L)1 | 1.39 (0.89, 1.71) | 1.61 (0.8, 1.82) | 1.92 (1.58, 2.24) | 0.003 |
HDL2 cholesterol (mmol/L)1 | 0.600 (0.425, 0.735) | 0.470 (0.360, 0.725) | 0.540 (0.415, 0.820) | 0.19 |
HDL3 cholesterol (mmol/L)1 | 0.395 (0.285, 0.505) | 0.330 (0.205, 0.450) | 0.325 (0.250, 0.570) | 0.43 |
VLDL triglyceride (mmol/L)1 | 0.338 (0.223, 0.440) | 0.263 (0.213, 0.365) | 0.265 (0.105, 0.353) | 0.37 |
LDL triglyceride (mmol/L)1 | 0.270 (0.170, 0.505) | 0.250 (0.170, 0.360) | 0.275 (0.125, 0.385) | 0.16 |
HDL2 triglyceride (mmol/L)1 | 0.080 (0.055, 0.138) | 0.070 (0.043, 0.093) | 0.060 (0.028, 0.100) | 0.09 |
HDL3 triglyceride (mmol/L)1 | 0.058 (0.035, 0.083) | 0.035 (0.013, 0.045) | 0.038 (0.025, 0.065) | 0.12 |
- Citation: Patel JV, Banerjee A, Montoro-Garcia S, Shantsila E, Alam M, Flinders P, Houlton KA, Hughes EA, Lip GY, Gill PS. CD36 expression and lipid metabolism following an oral glucose challenge in South Asians. World J Diabetes 2015; 6(7): 983-989
- URL: https://www.wjgnet.com/1948-9358/full/v6/i7/983.htm
- DOI: https://dx.doi.org/10.4239/wjd.v6.i7.983